Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 41 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2014A pilot study to assess the impact of patient, genetic and disease factors on response to the disease modifying anti-rheumatic drug leflunomideWiese, M.; Hopkins, A.; Spargo, L.; McWilliams, L.; O'Doherty, C.; Cleland, L.; Proudman, S.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2013Effect of fish oil on structural progression in knee osteoarthritis: a two year randomized, double-blind clinical trial comparing high dose with low doseHill, C.; Jones, G.; Lester, S.; Battersby, R.; Fedorova, T.; Hynes, K.; Proudman, S.; Cleland, L.; March, L.; 2013 ACR/ARHP Annual Meeting (25 Oct 2013 - 30 Oct 2013 : San Diego, CA)
2016Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high doseHill, C.; March, L.; Aitken, D.; Lester, S.; Battersby, R.; Hynes, K.; Fedorova, T.; Proudman, S.; James, M.; Cleland, L.; Jones, G.
2003The role of fish oils in the treatment of rheumatoid arthritisCleland, L.; James, M.; Proudman, S.
2006Fish oil: what the prescriber needs to knowCleland, L.; James, M.; Proudman, S.
2015The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies - a systematic reviewMohamed, H.; Sorich, M.; Kowalski, S.; McKinnon, R.; Proudman, S.; Cleland, L.; Wiese, M.
2016Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohortWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2012Active foot synovitis in patients with rheumatoid arthritis: applying clinical criteria for disease activity and remission may result in underestimation of foot joint involvementWechalekar, M.; Lester, S.; Proudman, S.; Cleland, L.; Whittle, S.; Rischmueller, M.; Hill, C.
2012Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritisWiese, M.; Schnabl, M.; O'Doherty, C.; Spargo, L.; Sorich, M.; Cleland, L.; Proudman, S.
2009Treatment-induced stable, moderate reduction in blood cell counts correlate to disease control in early rheumatoid arthritisLester, S.; Proudman, S.; Lee, A.; Hall, C.; McWilliams, L.; James, M.; Cleland, L.